OTCPK:RYMD.F

Stock Analysis Report

Executive Summary

Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Share Price & News

How has Relay Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

RYMD.F

1.9%

US Medical Equipment

0.5%

US Market


1 Year Return

-15.4%

RYMD.F

15.6%

US Medical Equipment

6.8%

US Market

Return vs Industry: RYMD.F underperformed the US Medical Equipment industry which returned 15.6% over the past year.

Return vs Market: RYMD.F underperformed the US Market which returned 6.8% over the past year.


Shareholder returns

RYMD.FIndustryMarket
7 Day0%1.9%0.5%
30 Day-22.4%-2.1%-0.8%
90 Day8.7%-0.4%-0.9%
1 Year-15.4%-15.4%16.6%15.6%9.2%6.8%
3 Year31.9%31.9%72.2%67.0%45.6%36.2%
5 Yearn/a125.9%100.9%63.2%45.4%

Price Volatility Vs. Market

How volatile is Relay Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Relay Medical undervalued compared to its fair value and its price relative to the market?

5.96x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate RYMD.F's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate RYMD.F's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: RYMD.F is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: RYMD.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate RYMD.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: RYMD.F is overvalued based on its PB Ratio (6x) compared to the US Medical Equipment industry average (3.8x).


Next Steps

Future Growth

How is Relay Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Relay Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Examine Relay Medical's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Relay Medical's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Relay Medical performed over the past 5 years?

-34.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: RYMD.F is unprofitable, and losses have increased over the past 5 years at a rate of -34.8% per year.

Accelerating Growth: Unable to compare RYMD.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RYMD.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.2%).


Return on Equity

High ROE: RYMD.F has a negative Return on Equity (-143.62%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: RYMD.F is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: RYMD.F is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Relay Medical's financial position?


Financial Position Analysis

Short Term Liabilities: RYMD.F's short term assets (CA$963.7K) exceeds its short term liabilities (CA$521.5K)

Long Term Liabilities: RYMD.F has no long term liabilities


Debt to Equity History and Analysis

Debt Level: RYMD.F is debt free.

Reducing Debt: RYMD.F had no debt 5 years ago.


Balance Sheet

Inventory Level: RYMD.F has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if RYMD.F's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RYMD.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: RYMD.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of -63.6% each year


Next Steps

Dividend

What is Relay Medical's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate RYMD.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate RYMD.F's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if RYMD.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if RYMD.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of RYMD.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Relay Medical's salary, the management and board of directors tenure and is there insider trading?

1.6yrs

Average management tenure


CEO

Lahav Gil 0

1.8yrs

Tenure

CA$374,170

Compensation

Mr. Lahav Gil is Chief Executive Officer and Director at Relay Medical Corp. since January 2018. Mr. Gil serves as Vice President of Innovation at StarFish Product Engineering Inc. Mr. Gil has been Chief E ...


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether Lahav's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Lahav's compensation with company performance.


Management Age and Tenure

1.6yrs

Average Tenure

Experienced Management: RYMD.F's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Age and Tenure

2.5yrs

Average Tenure

Experienced Board: RYMD.F's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyCA$137,74515 Jul 19
Imperial Consultants Inc
EntityCompany
Shares700,000
Max PriceCA$0.25
BuyCA$6,89611 Jun 19
W. Kent
EntityIndividual
Role
President
President
Shares48,500
Max PriceCA$0.14
BuyCA$3,93428 Jan 19
W. Kent
EntityIndividual
Role
President
President
Shares25,000
Max PriceCA$0.16
BuyCA$7,48714 Jan 19
Michael Minder
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares45,600
Max PriceCA$0.17
BuyCA$7,14002 Jan 19
W. Kent
EntityIndividual
Role
President
President
Shares43,500
Max PriceCA$0.17
BuyCA$6,57425 Dec 18
Michael Minder
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares40,000
Max PriceCA$0.17
BuyCA$4,03725 Dec 18
W. Kent
EntityIndividual
Role
President
President
Shares23,500
Max PriceCA$0.17

Ownership Breakdown


Management Team

  • Gerard Edwards

    Executive Chairman

    • Tenure: 0yrs
  • Chris Hopkins (56yo)

    Chief Financial Officer

    • Tenure: 5.3yrs
    • Compensation: CA$16.00k
  • John Soloninka

    Senior Vice-President of Acquisitions & Exits

    • Tenure: 0.8yrs
  • Lahav Gil

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: CA$374.17k
  • Ash Kaushal

    Consultant

    • Tenure: 1.8yrs
  • Raj Kailasanathan

    Executive Vice President of Corporate Finance.

    • Tenure: 1.6yrs
  • W. Kent

    President

    • Tenure: 1.8yrs
    • Compensation: CA$254.22k
  • iGAL Roytblat

    Chief Technology Officer

    • Tenure: 1.6yrs
  • Tom Glawdel

    Chief Scientific Officer

    • Tenure: 1.3yrs
  • Adam Liederman

    Chief Operating Officer

    • Tenure: 0.3yrs

Board Members

  • Gerard Edwards

    Executive Chairman

    • Tenure: 0yrs
  • Mike Minder

    Independent Director

    • Tenure: 5.3yrs
    • Compensation: CA$40.00k
  • John Ormston (52yo)

    Member of Advisory Board

    • Tenure: 2.5yrs
  • Cynthia Balion

    Member of Technical Advisory Board

    • Tenure: 5yrs
  • Robert Smyth

    Member of Technical Advisory Board

    • Tenure: 4.6yrs
  • Lahav Gil

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: CA$374.17k
  • Brian Cameron

    Member of Advisory Board

    • Tenure: 2.5yrs
  • Greg Falck

    Member of Advisory Board

    • Tenure: 2.4yrs
  • Sid Thomas

    Independent Director

    • Tenure: 0.5yrs
  • Medhanie Tekeste

    Independent Director

    • Tenure: 0.5yrs

Company Information

Relay Medical Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Relay Medical Corp.
  • Ticker: RYMD.F
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$26.210m
  • Listing Market Cap: CA$19.956m
  • Shares outstanding: 124.81m
  • Website: https://www.relaymedical.com

Location

  • Relay Medical Corp.
  • 401 Bay Street
  • Suite 1600
  • Toronto
  • Ontario
  • M5H 2Y4
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RELACNSX (Canadian National Stock Exchange)YesNew Common SharesCACADOct 2006
EIY2DB (Deutsche Boerse AG)YesNew Common SharesDEEUROct 2006
RYMD.FOTCPK (Pink Sheets LLC)YesNew Common SharesUSUSDOct 2006

Biography

Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. It provides HemoPalm, a blood analysis system that integrates blood gases, electrolytes, CO ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/21 00:35
End of Day Share Price2019/10/11 00:00
Earnings2019/06/30
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.